ERS Genomics Licenses CRISPR Patents to University of Tübingen – GenomeWeb
|
ERS Genomics Licenses CRISPR Patents to University of Tübingen
GenomeWeb NEW YORK (GenomeWeb) – ERS Genomics said today that it has licensed its CRISPR-Cas9 genome editing patents to the NMI Natural and Medical Sciences Institute at the University of Tübingen and its affiliate NMI TT Pharmaservices. Under the terms of … ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to NMI and NMI TT Pharmaservices |
